EDGAR Filing Documents for 0001193125-20-209797

Form 8-K - Current report:

SEC Accession No. 0001193125-20-209797

Filing Date

2020-08-05

Accepted

2020-08-05 06:09:29

Documents

Period of Report

2020-08-05

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d79713d8k.htm	8-K	16464
2	EX-99.1	d79713dex991.htm	EX-99.1	56316
3	GRAPHIC	g79713dsp2.jpg	GRAPHIC	5599
	Complete submission text file	0001193125-20-209797.txt		81730

Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110

Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244

Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38958 | Film No.: 201075497
SIC: 2834 Pharmaceutical Preparations